A prospective multi-institutional validity study to evaluate the accuracy of clinical diagnosis of pathological stage III gastric cancer (JCOG1302A).

Takeo FukagawaHitoshi KataiJunki MizusawaKenichi NakamuraTakeshi SanoMasanori TerashimaSeiji ItoTakaki YoshikawaNorimasa FukushimaYasuyuki KawachiTakahiro KinoshitaYutaka KimuraHiroshi YabusakiYasunori NishidaYoshiaki IwasakiSang-Woong LeeTakashi YasudaMitsuru Sasakonull null

Published in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2017)

Clinical diagnosis of T3/T4 tumors was not an optimal criterion to select patients for intensive NAC trials because more than 10% of patients with pathological stage I disease were included. We propose the criterion "cT3/T4 and cN1/N2/N3" instead.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
computed tomography
transcription factor
prognostic factors
magnetic resonance imaging
contrast enhanced
phase iii